Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness

Meysam Amidfar, Yong Ku Kim, Lejla Colic, Mohammad Arbabi, Gholamhossein Mobaraki, Gholamreza Hassanzadeh, Martin Walter

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Neuroimaging, immunologic, and pharmacologic studies have emphasized the role of 5-HT2A and 5-HT3A serotonin receptors in the pathophysiology of major depression. Aim: The aim of this study was to measure the relative expression of 5-HT2A and 5-HT3A receptor mRNA in peripheral blood mononuclear cells (PBMCs) of patients with major depressive disorder (MDD). Method: 5-HT2A and 5-HT3A receptor mRNA expressions were examined in PBMCs of 25 medication-naïve-patients with MDD, 25 medication-free MDD patients, and 25 healthy controls. 5-HT2A and 5-HT3A receptor mRNA expressions were measured using real-time quantitative PCR. This study evaluated patients’ clinical symptoms using the Hamilton Depression Rating Scale-17 items (HDRS) and the Beck Depression Inventory (BDI). Results: Relative 5-HTR2A mRNA expression was significantly higher in PBMCs of all MDD patients when compared with healthy controls (Z = −3.875, p < 0.05). However, there was no significant difference in the relative levels of 5-HTR3A mRNA expression in PBMCs of all MDD patients when compared with healthy controls (Z = −1.328, p > 0.05). MDD patients showed significant correlations between 5-HTR2A mRNA expression and HDRS scores (rs = 0.902, p < 0.001) and BDI scores (rs = 0.878, p < 0.001). Conclusion: This study showed that depressed patients, irrespective of treatment, have higher 5-HTR2A mRNA levels in PBMCs than healthy subjects. It also provided evidence that 5-HTR2A mRNA levels in PBMCs of MDD patients could be associated with the severity of depression and the duration of the illness.

Original languageEnglish
Pages (from-to)282-288
Number of pages7
JournalNordic Journal of Psychiatry
Volume71
Issue number4
DOIs
Publication statusPublished - 2017 May 19

Fingerprint

Blood Cells
Major Depressive Disorder
Depression
Messenger RNA
Receptor, Serotonin, 5-HT2A
Receptors, Serotonin, 5-HT3
Equipment and Supplies
Neuroimaging
Real-Time Polymerase Chain Reaction
Healthy Volunteers

Keywords

  • 5-HT2A receptor
  • 5-HT3A receptor
  • Major depression
  • mRNA expression
  • PBMCs

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression : correlations with severity and duration of illness. / Amidfar, Meysam; Kim, Yong Ku; Colic, Lejla; Arbabi, Mohammad; Mobaraki, Gholamhossein; Hassanzadeh, Gholamreza; Walter, Martin.

In: Nordic Journal of Psychiatry, Vol. 71, No. 4, 19.05.2017, p. 282-288.

Research output: Contribution to journalArticle

Amidfar, Meysam ; Kim, Yong Ku ; Colic, Lejla ; Arbabi, Mohammad ; Mobaraki, Gholamhossein ; Hassanzadeh, Gholamreza ; Walter, Martin. / Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression : correlations with severity and duration of illness. In: Nordic Journal of Psychiatry. 2017 ; Vol. 71, No. 4. pp. 282-288.
@article{e6b0f2f4a49f4ac1afcf02fda6f2aadf,
title = "Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness",
abstract = "Background: Neuroimaging, immunologic, and pharmacologic studies have emphasized the role of 5-HT2A and 5-HT3A serotonin receptors in the pathophysiology of major depression. Aim: The aim of this study was to measure the relative expression of 5-HT2A and 5-HT3A receptor mRNA in peripheral blood mononuclear cells (PBMCs) of patients with major depressive disorder (MDD). Method: 5-HT2A and 5-HT3A receptor mRNA expressions were examined in PBMCs of 25 medication-na{\"i}ve-patients with MDD, 25 medication-free MDD patients, and 25 healthy controls. 5-HT2A and 5-HT3A receptor mRNA expressions were measured using real-time quantitative PCR. This study evaluated patients’ clinical symptoms using the Hamilton Depression Rating Scale-17 items (HDRS) and the Beck Depression Inventory (BDI). Results: Relative 5-HTR2A mRNA expression was significantly higher in PBMCs of all MDD patients when compared with healthy controls (Z = −3.875, p < 0.05). However, there was no significant difference in the relative levels of 5-HTR3A mRNA expression in PBMCs of all MDD patients when compared with healthy controls (Z = −1.328, p > 0.05). MDD patients showed significant correlations between 5-HTR2A mRNA expression and HDRS scores (rs = 0.902, p < 0.001) and BDI scores (rs = 0.878, p < 0.001). Conclusion: This study showed that depressed patients, irrespective of treatment, have higher 5-HTR2A mRNA levels in PBMCs than healthy subjects. It also provided evidence that 5-HTR2A mRNA levels in PBMCs of MDD patients could be associated with the severity of depression and the duration of the illness.",
keywords = "5-HT2A receptor, 5-HT3A receptor, Major depression, mRNA expression, PBMCs",
author = "Meysam Amidfar and Kim, {Yong Ku} and Lejla Colic and Mohammad Arbabi and Gholamhossein Mobaraki and Gholamreza Hassanzadeh and Martin Walter",
year = "2017",
month = "5",
day = "19",
doi = "10.1080/08039488.2016.1276624",
language = "English",
volume = "71",
pages = "282--288",
journal = "Nordic Journal of Psychiatry",
issn = "0803-9488",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression

T2 - correlations with severity and duration of illness

AU - Amidfar, Meysam

AU - Kim, Yong Ku

AU - Colic, Lejla

AU - Arbabi, Mohammad

AU - Mobaraki, Gholamhossein

AU - Hassanzadeh, Gholamreza

AU - Walter, Martin

PY - 2017/5/19

Y1 - 2017/5/19

N2 - Background: Neuroimaging, immunologic, and pharmacologic studies have emphasized the role of 5-HT2A and 5-HT3A serotonin receptors in the pathophysiology of major depression. Aim: The aim of this study was to measure the relative expression of 5-HT2A and 5-HT3A receptor mRNA in peripheral blood mononuclear cells (PBMCs) of patients with major depressive disorder (MDD). Method: 5-HT2A and 5-HT3A receptor mRNA expressions were examined in PBMCs of 25 medication-naïve-patients with MDD, 25 medication-free MDD patients, and 25 healthy controls. 5-HT2A and 5-HT3A receptor mRNA expressions were measured using real-time quantitative PCR. This study evaluated patients’ clinical symptoms using the Hamilton Depression Rating Scale-17 items (HDRS) and the Beck Depression Inventory (BDI). Results: Relative 5-HTR2A mRNA expression was significantly higher in PBMCs of all MDD patients when compared with healthy controls (Z = −3.875, p < 0.05). However, there was no significant difference in the relative levels of 5-HTR3A mRNA expression in PBMCs of all MDD patients when compared with healthy controls (Z = −1.328, p > 0.05). MDD patients showed significant correlations between 5-HTR2A mRNA expression and HDRS scores (rs = 0.902, p < 0.001) and BDI scores (rs = 0.878, p < 0.001). Conclusion: This study showed that depressed patients, irrespective of treatment, have higher 5-HTR2A mRNA levels in PBMCs than healthy subjects. It also provided evidence that 5-HTR2A mRNA levels in PBMCs of MDD patients could be associated with the severity of depression and the duration of the illness.

AB - Background: Neuroimaging, immunologic, and pharmacologic studies have emphasized the role of 5-HT2A and 5-HT3A serotonin receptors in the pathophysiology of major depression. Aim: The aim of this study was to measure the relative expression of 5-HT2A and 5-HT3A receptor mRNA in peripheral blood mononuclear cells (PBMCs) of patients with major depressive disorder (MDD). Method: 5-HT2A and 5-HT3A receptor mRNA expressions were examined in PBMCs of 25 medication-naïve-patients with MDD, 25 medication-free MDD patients, and 25 healthy controls. 5-HT2A and 5-HT3A receptor mRNA expressions were measured using real-time quantitative PCR. This study evaluated patients’ clinical symptoms using the Hamilton Depression Rating Scale-17 items (HDRS) and the Beck Depression Inventory (BDI). Results: Relative 5-HTR2A mRNA expression was significantly higher in PBMCs of all MDD patients when compared with healthy controls (Z = −3.875, p < 0.05). However, there was no significant difference in the relative levels of 5-HTR3A mRNA expression in PBMCs of all MDD patients when compared with healthy controls (Z = −1.328, p > 0.05). MDD patients showed significant correlations between 5-HTR2A mRNA expression and HDRS scores (rs = 0.902, p < 0.001) and BDI scores (rs = 0.878, p < 0.001). Conclusion: This study showed that depressed patients, irrespective of treatment, have higher 5-HTR2A mRNA levels in PBMCs than healthy subjects. It also provided evidence that 5-HTR2A mRNA levels in PBMCs of MDD patients could be associated with the severity of depression and the duration of the illness.

KW - 5-HT2A receptor

KW - 5-HT3A receptor

KW - Major depression

KW - mRNA expression

KW - PBMCs

UR - http://www.scopus.com/inward/record.url?scp=85010669567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010669567&partnerID=8YFLogxK

U2 - 10.1080/08039488.2016.1276624

DO - 10.1080/08039488.2016.1276624

M3 - Article

C2 - 28125323

AN - SCOPUS:85010669567

VL - 71

SP - 282

EP - 288

JO - Nordic Journal of Psychiatry

JF - Nordic Journal of Psychiatry

SN - 0803-9488

IS - 4

ER -